Kurapa kwechimurenga kunogona kuve mushonga unoshanda werelapsed leukemia

Mumwe wevanotungamira oncologists pasirese anotenda kuti immunotherapies itsva yeanodaidzwa kuti "mishonga mhenyu" inogona kunge iri "chombo chepamusoro-soro mukurwisa leukemia", ichipa kuvandudzwa kwakanyanya muhuwandu hwekupona.

Dr. Rabih Hanna, chiremba wezvemahematologist evana, oncologist uye nyanzvi yekuisa mapfupa emapfupa kuCleveland Clinic muUnited States, ari kushanyira Arab Health Exhibition and Conference iri kuitirwa kuDubai, akati kurapwa ne chimeric receptors yeT masero, anozivikanwa. se "karti" MOTO TInobva pakubvisa masero eT kubva mumuviri wemurwere uye nekuagadzirisa murabhoritari kurwisa cancer maseru.

Ropa remurwere rinodhonzwa uye shanduko yerabhoritari inoitwa kuT masero, ari rudzi rwesero re immune system, kuti rikwanise kurwisa nekuuraya masero egomarara. Masero eKarti akagadziridzwa anopinzwa mumuviri wemurwere kuburikidza neropa, mukati memazuva gumi nemana ekurapwa.

Cleveland Clinic Vana ndechimwe chezvipatara zvekutanga kupa chimeric T-cell therapy kuvana vane cancer, kurapwa kwave kubvumidzwa kushandiswa muUnited States neEurope.

Dr. Hanna akasimbisa migumisiro yekutanga yekushandisa chimeric receptor T-cell (Karti) therapy mukurapa kwevana nevechidiki vane pre-B-cell acute lymphoblastic leukemia. BImwe mhando ye lymphoma DLBCL (Inoparadzirwa hombe B-cell lymphoma) “inovimbisa uye inofadza,” ichitsanangura kurapa uku so“mushonga womunhu oga wakagadzirirwa kurwisa leukemia nokusingaperi” nokuti unoramba uri muropa somushonga mhenyu, uye akawedzera kuti: “T-cell therapy inopa Kunyanya kugona mukurapa leukemia, kwete Kunyanya pakati pevarwere vari pasi pemakore makumi maviri nematanhatu vane relapsing acute lymphoblastic leukemia.

Muhurukuro yake paArab Health Conference, Dr. Hanna akarongerwa kugadzirisa matambudziko nemikana mukurapa kenza muvana, vechidiki uye vechidiki. Anotenda kuti kushanda kweT-cell therapy kunogona kuratidza kunyange kune vanhu vakuru vane non-Hodgkin's hombe B-cell lymphoma.

Uye Dr. Hanna akagumisa nokuti: “Iye zvino tiri kupupurira kusvetuka kukuru mumwero yokupukunyuka, nehwerengedzo ye70 kana kuti 80 muzana.”

Maererano naDr. Hanna, T-cell therapy iye zvino iri kugadzirwa kurapa mamwe magomarara eropa, akadai sechronic lymphocytic leukemia uye mamwe marudzi e lymphoma uye multiple myeloma.

Musangano wechimakumi mana nemana weArab Health uchaitwa kubva 28-31 Ndira kuDubai World Trade Center uye Conrad Dubai Hotel.